Global distribution of Klebsiella pneumoniae producing extended-spectrum β-lactamases in neonates

i

This article has been updated. A Correction to this article was published on .

i

The Original Article was published on

i

The Original Article was published on

i

This article has been updated

i

This article was retracted on

i

This article has been updated

Acknowledgements

The work was supported by the National Key Research and Development Program of China (Grant No. 2023YFC2308800), the Natural Science Foundation of Sichuan Province (Grant No. 2023NSFSC1697), and the 1.3.5 Project for Disciplines of Excellence, West China Hospital of Sichuan University (Grant No. ZYGD22001).

Author contributions

Ya Hu (Conceptualization, Data curation, Funding acquisition, Investigation, Writing—original draft), Yu Feng (Data curation, Formal analysis, Funding acquisition, Validation), and Zhiyong Zong (Conceptualization, Funding acquisition, Supervision, Writing—review & editing).

Supplementary data

Supplementary data is available at PCMEDI Journal online.

Conflict of Interest

None declared.

CHANGE HISTORY

A Correction to this paper has been published:
https://doi.org

The Retraction Note was updated to reflect reception of statements of disagreement from all authors.

This article has been retracted.Please see the Retraction Notice for more detail:
https://doi.org

References

[1] Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 1998;11:589-603. https://doi.org/10.1128/CMR.11.4.589.

[2] Murray CJL, Ikuta KS, Sharara F et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet North Am Ed 2022;399:629-55. https://doi.org/10.1016/S0140-6736(21)02724-0.

[3] WHO Bacterial Priority Pathogens List, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. Geneva: World Health Organization, 2024.

[4] Laxminarayan R, Bhutta ZA. Antimicrobial resistance-a threat to neonate survival. Lancet Glob Health 2016;4:e676-7. https://doi.org/10.1016/S2214-109X(16)30221-2.

[5] Russell NJ, Stöhr W, Plakkal N et al. Patterns of antibiotic use, pathogens, and prediction of mortality in hospitalized neonates and young infants with sepsis: A global neonatal sepsis observational cohort study (NeoOBS). PLoS Med 2023;20:e1004179. https://doi.org/10.1371/journal.pmed.1004179.

[6] Long H, Hu Y, Feng Y et al. Genome analysis of Klebsiella oxytoca complex for antimicrobial resistance and virulence genes. Antimicrob Agents Chemother 2022;66:e0218321. https://doi.org/10.1128/aac.02183-21.

[7] Hu Y, Yang Y, Feng Y et al. Prevalence and clonal diversity of carbapenem-resistant Klebsiella pneumoniae causing neonatal infections: A systematic review of 128 articles across 30 countries. PLoS Med 2023;20:e1004233. https://doi.org/10.1371/journal.pmed.1004233.

[8] Rossolini GM, D'Andrea MM, Mugnaioli C. The spread of CTX-M-type extended-spectrum β-lactamases. Clin Microbiol Infect 2008;14:33-41. https://doi.org/10.1111/j.1469-0691.2007.01867.x.

[9] Castanheira M, Simner PJ, Bradford PA. Extended-spectrum β lactamases: an update on their characteristics, epidemiology and detection. JAC Antimicrob Resist 2021;3:dlab092. https://doi.org/10.1093/jacamr/dlab092.

[10] Baek EH, Kim SE, Kim S et al. Successful control of an extendedspectrum beta-lactamase-producing Klebsiella pneumoniae ST 307 outbreak in a neonatal intensive care unit. BMC Infect Dis 2020;20:166. https://doi.org/10.1186/s12879-020-4889-z.